| Laura Lee Nelsen, MD | |
|
6 E Chestnut St, Augusta, ME 04330-5717 | |
| (605) 670-9580 | |
| Not Available |
| Full Name | Laura Lee Nelsen |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 18 Years |
| Location | 6 E Chestnut St, Augusta, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770704728 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 04-32610 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Maine General Medical Center | Augusta, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Pathology Associates, Pa | 1355416926 | 5 |
News Archive
The neck and arm pain caused by degenerative cervical (neck) disc disease may be eliminated by replacing the problem disc with a metal-on-metal artificial disc, said Loyola University Health System neurological surgeon Dr. Russ P. Nockels.
SQI Diagnostics Inc. (TSX-V: SQD), a medical systems company focused on evolving laboratory-based biomarker testing, today announced that it closed its previously announced, brokered private placement (the "Private Placement") for gross proceeds of $6,594,786.
Two new compounds created by a University of Central Florida professor show early promise for destroying breast cancer tumors.
EntreMed a clinical-stage pharmaceutical company developing therapeutics primarily for the treatment of cancer and inflammatory diseases, has announced the presentation of positive preclinical results for its lead compound, 2-methoxyestradiol (2ME2), in models of rheumatoid arthritis.
Eradication of Helicobacter pylori is a well-accepted initial therapy in cases of localized (stage ⅠE) low-grade gastric mucosa-associated lymphoid tissue lymphoma associated with H. pylori infection. However, there are no treatment guidelines for the management of H. pylori-negative low-grade gastric MALT lymphoma.
› Verified 3 days ago
| Entity Name | The Pathology Associates, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346300738 PECOS PAC ID: 1355416926 Enrollment ID: O20080819000643 |
News Archive
The neck and arm pain caused by degenerative cervical (neck) disc disease may be eliminated by replacing the problem disc with a metal-on-metal artificial disc, said Loyola University Health System neurological surgeon Dr. Russ P. Nockels.
SQI Diagnostics Inc. (TSX-V: SQD), a medical systems company focused on evolving laboratory-based biomarker testing, today announced that it closed its previously announced, brokered private placement (the "Private Placement") for gross proceeds of $6,594,786.
Two new compounds created by a University of Central Florida professor show early promise for destroying breast cancer tumors.
EntreMed a clinical-stage pharmaceutical company developing therapeutics primarily for the treatment of cancer and inflammatory diseases, has announced the presentation of positive preclinical results for its lead compound, 2-methoxyestradiol (2ME2), in models of rheumatoid arthritis.
Eradication of Helicobacter pylori is a well-accepted initial therapy in cases of localized (stage ⅠE) low-grade gastric mucosa-associated lymphoid tissue lymphoma associated with H. pylori infection. However, there are no treatment guidelines for the management of H. pylori-negative low-grade gastric MALT lymphoma.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Laura Lee Nelsen, MD 105 E Side Trl, Oakland, ME 04963 Ph: (605) 670-9580 | Laura Lee Nelsen, MD 6 E Chestnut St, Augusta, ME 04330-5717 Ph: (605) 670-9580 |
News Archive
The neck and arm pain caused by degenerative cervical (neck) disc disease may be eliminated by replacing the problem disc with a metal-on-metal artificial disc, said Loyola University Health System neurological surgeon Dr. Russ P. Nockels.
SQI Diagnostics Inc. (TSX-V: SQD), a medical systems company focused on evolving laboratory-based biomarker testing, today announced that it closed its previously announced, brokered private placement (the "Private Placement") for gross proceeds of $6,594,786.
Two new compounds created by a University of Central Florida professor show early promise for destroying breast cancer tumors.
EntreMed a clinical-stage pharmaceutical company developing therapeutics primarily for the treatment of cancer and inflammatory diseases, has announced the presentation of positive preclinical results for its lead compound, 2-methoxyestradiol (2ME2), in models of rheumatoid arthritis.
Eradication of Helicobacter pylori is a well-accepted initial therapy in cases of localized (stage ⅠE) low-grade gastric mucosa-associated lymphoid tissue lymphoma associated with H. pylori infection. However, there are no treatment guidelines for the management of H. pylori-negative low-grade gastric MALT lymphoma.
› Verified 3 days ago
Dr. Carol Anne Saunders, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 6 E Chestnut St, Dept Of Pathology, Augusta, ME 04330 Phone: 207-626-1409 Fax: 207-626-1046 | |
Dr. Ross A Metzman, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 6 E Chestnut St, Mgmc Pathology, Augusta, ME 04330 Phone: 207-626-1409 | |
Liam Eirik Funte, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 30 Hospital Street, Ocme, Augusta, ME 04330 Phone: 207-624-7185 | |
Cheri Lynn Aubertine, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 6 E Chestnut St, Augusta, ME 04330 Phone: 207-626-1410 | |
John Joseph Oprendek Jr., M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 6 E Chestnut St, Augusta, ME 04330 Phone: 207-626-1409 Fax: 207-626-1046 | |
Vincent Gemellaro, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Va Ctr, Laboratory 113, Augusta, ME 04330 Phone: 207-623-8411 Fax: 207-621-7314 |